Eye drop vs. pill: race to stop a virus that steals sight
NCT ID NCT03586284
Summary
This study aimed to find the best way to treat a painful and potentially blinding eye infection called cytomegalovirus (CMV) anterior uveitis. It compared an oral antiviral pill (valganciclovir) against an antiviral eye drop (ganciclovir 2%) and a placebo in 51 adults with a confirmed diagnosis. The goal was to see which treatment most effectively reduced the amount of virus in the eye and controlled the inflammation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS ANTERIOR UVEITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chiang Mai University
Chiang Mai, Thailand
-
Chulalongkorn University
Bangkok, Thailand
-
Khon Kaen University
Khon Kaen, Thailand
-
Proctor Foundation, UCSF
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.